Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/tech
Clear filters and search
Format
photo
Tags
cancer
3
×
biotech
clinical trials
life sciences
national blog main
abbvie
acerta pharma
adage capital management
antibody drugs
antibody-drug conjugate
arix
arix bioscience
articles
artificial intelligence
astrazeneca
bispecific antibodies
boston
boston blog main
boston top stories
breast cancer
bridgebio pharma
calistoga pharmaceuticals
citadel
clayton knox
cormorant asset management
cowen healthcare investments
cullinan oncology
dave johnson
decheng capital
deep learning
emerging-technologies
f2 ventures
farallon
financing
foresite capital
funding
funds and accounts advised by t. rowe price associates
gilead sciences
health
janus henderson investors
What
advance
3
×
cancer
years
3
×
based
drug
drugs
nearly
ago
antibody
anticipate
approach
artificial
black
breast
ceo
cullinan
dave
deep
developed
development
diego
early
emerged
equally
founders
improve
intelligence
johnson
kipps
known
lab
learning
mit’s
model
new
odds
oncology
patients
physician
pipeline
Language
unset
Current search:
cancer
×
advance
×
years
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}